High serum leptin is an independent risk factor for non-response patients with low viremia to antiviral treatment in chronic hepatitis C

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 4

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

245

HTML

1829

Figures (1-2)

140

Tables (1-2)

122

Sum=2336

Jan 28, 2006 (publication date) through Jun 29, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Viral Hepatitis

World J Gastroenterol. Jan 28, 2006; 12(4): 556-560
Published online Jan 28, 2006. doi: 10.3748/wjg.v12.i4.556

Table 2 Multivariate analysis of parameters

		P	Odds ratio	RR (95%CI)
independently influenced SR (n = 33)	Serotype	0.93	1.05	(0.34-3.32)
	HCV RNA	< 0.0001	12.74	(4.15-39.08)
	Fibrosis	0.18	0.49	(0.18-1.39)
	Leptin level	0.14	2.87	(0.18-11.63)
50 subjects with low viremia level	Serotype	0.95	0.25	(0.25-3.63)
	Fibrosis	0.14	0.37	(0.1-1.4)
	Leptin level	< 0.05	9.38	(0.99-88.85)

Citation: Eguchi Y, Mizuta T, Yasutake T, Hisatomi A, Iwakiri R, Ozaki I, Fujimoto K. High serum leptin is an independent risk factor for non-response patients with low viremia to antiviral treatment in chronic hepatitis C. World J Gastroenterol 2006; 12(4): 556-560
URL: https://www.wjgnet.com/1007-9327/full/v12/i4/556.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i4.556